To further explore the in vivo mechanism of METTL3/14 methyltransferases in EZMLD treatment, ovarian cancer xenografts were established in nude mice with SKOV3 cells with METTL3 and METTL14 knockdown. Here, METTL14 is linked to ovarian carcinoma.